大禹生物
(920970)
| 流通市值：4.93亿 | | | 总市值：7.80亿 |
| 流通股本：7007.13万 | | | 总股本：1.11亿 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 29,126,660.12 | 30,394,424.58 | 22,100,328.32 | 45,824,856.62 |
| 应收票据及应收账款 | 18,481,464.36 | 17,652,550.25 | 21,812,372.57 | 22,625,762.82 |
| 应收账款 | 18,481,464.36 | 17,652,550.25 | 21,812,372.57 | 22,625,762.82 |
| 应收款项融资 | 42,000 | 126,238 | 94,250 | - |
| 预付款项 | 4,773,084.56 | 3,596,533.53 | 3,984,376.64 | 4,525,487.18 |
| 其他应收款合计 | 112,719.16 | 112,486.85 | 85,565.07 | 67,270.45 |
| 存货 | 38,231,105.97 | 35,658,542.21 | 65,245,822.16 | 34,049,215.87 |
| 其他流动资产 | 2,144,513.18 | 2,357,709.54 | 740,737.62 | 740,737.62 |
| 流动资产合计 | 92,911,547.35 | 89,898,484.96 | 114,063,452.38 | 107,833,330.56 |
| 非流动资产: | | | | |
| 固定资产 | 268,143,761.46 | 274,153,873.87 | 265,536,816.53 | 272,401,306.89 |
| 在建工程 | 29,660,624.19 | 22,082,690.79 | 17,405,768.52 | 4,206,521.13 |
| 使用权资产 | 8,321,779.81 | 9,879,097.24 | 9,974,254.99 | 8,896,450.22 |
| 无形资产 | 24,275,490.16 | 24,586,299.91 | 24,627,198.15 | 24,924,733.56 |
| 其他非流动资产 | 23,937,479.27 | 15,211,529.99 | 23,950,711.64 | 17,743,872.64 |
| 非流动资产合计 | 354,339,134.89 | 345,913,491.8 | 341,494,749.83 | 328,172,884.44 |
| 资产总计 | 447,250,682.24 | 435,811,976.76 | 455,558,202.21 | 436,006,215 |
| 流动负债: | | | | |
| 短期借款 | 111,300,000 | 83,482,211.11 | 84,000,000 | 74,000,000 |
| 应付票据及应付账款 | 10,886,161.32 | 14,652,528.7 | 15,215,010.8 | 9,207,679.67 |
| 应付账款 | 10,886,161.32 | 14,652,528.7 | 15,215,010.8 | 9,207,679.67 |
| 合同负债 | 2,243,093.35 | 2,210,075.83 | 4,044,107.16 | 1,523,392.59 |
| 应付职工薪酬 | 7,298,078.74 | 8,730,552.95 | 7,413,807.25 | 7,799,827.08 |
| 应交税费 | 810,961.74 | 410,398.25 | 444,821.97 | 694,670.13 |
| 其他应付款合计 | 3,183,953.17 | 2,662,757.44 | 809,644.86 | 469,368.9 |
| 一年内到期的非流动负债 | 3,075,510.52 | 3,117,280.9 | 3,096,449.53 | 2,627,522.16 |
| 流动负债合计 | 138,797,758.84 | 115,265,805.18 | 115,023,841.57 | 96,322,460.53 |
| 非流动负债: | | | | |
| 长期借款 | 23,100,000 | 15,075,000 | 15,075,000 | 12,500,000 |
| 租赁负债 | 7,994,559.67 | 9,568,241.43 | 9,455,236.83 | 8,282,397.74 |
| 递延收益 | 31,262,369.49 | 32,390,299.02 | 33,354,582.21 | 34,558,332.24 |
| 非流动负债合计 | 62,356,929.16 | 57,033,540.45 | 57,884,819.04 | 55,340,729.98 |
| 负债合计 | 201,154,688 | 172,299,345.63 | 172,908,660.61 | 151,663,190.51 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 110,800,800 | 110,800,800 | 111,360,400 | 111,360,400 |
| 资本公积 | 81,043,599.94 | 81,043,599.94 | 85,593,738.02 | 85,593,738.02 |
| 减:库存股 | - | - | 5,109,738.08 | 5,109,738.08 |
| 盈余公积 | 16,853,068.95 | 16,853,068.95 | 16,853,068.95 | 16,853,068.95 |
| 未分配利润 | 37,398,525.35 | 54,815,162.24 | 73,952,072.71 | 75,645,555.6 |
| 归属于母公司股东权益合计 | 246,095,994.24 | 263,512,631.13 | 282,649,541.6 | 284,343,024.49 |
| 股东权益合计 | 246,095,994.24 | 263,512,631.13 | 282,649,541.6 | 284,343,024.49 |
| 负债和股东权益合计 | 447,250,682.24 | 435,811,976.76 | 455,558,202.21 | 436,006,215 |
| 公告日期 | 2026-04-27 | 2026-04-27 | 2025-10-27 | 2025-08-25 |
| 审计意见(境内) | | 标准无保留意见 | | |